Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
CEO: Raza Bokhari. Company website
Medicus Pharma Ltd. Common Stock (MDCX) trades at $0.17, down 34.40% on the day, as of Sep 20, 2026 15:01 UTC.
Medicus Pharma Ltd. Common Stock has a market capitalisation of $3.76M, calculated from the live MDCX share price and shares outstanding.
MDCX has no meaningful price-to-earnings ratio: Medicus Pharma Ltd. Common Stock lost $2.40 per share over the last twelve months, and a P/E is only defined on positive earnings.
Medicus Pharma Ltd. Common Stock generated revenue of $0.00 over the trailing twelve months.
MDCX has traded between $0.15 and $1.55 over the past 52 weeks, and the last price is 89.0% below that high.
Yes. Medicus Pharma Ltd. Common Stock keeps 0.00% of revenue as net income over the trailing twelve months.
Wall Street analysts rate MDCX Buy.
Medicus Pharma Ltd. Common Stock is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in CA .
Raza Bokhari is the chief executive of Medicus Pharma Ltd. Common Stock, which employs 12 people.
QFI Terminal shows MDCX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open MDCX in Terminal See plans